Cover Image

Development and initial validation of a new functional ability tool for juvenile dermatomyositis

Saved in:

Bibliographic Details
Main Authors:	Demirkaya E (Author), Madeo A (Author), Rao AP (Author), Malattia C (Author), Consolaro A (Author), Varnier GC (Author), Lazarevic D (Author), Civino A (Author), Martini A (Author), Ravelli A (Author)
Format:	Book
Published:	BMC, 2011-09-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

The PRINTO provisional definition of remission in juvenile dermatomyositis
by: Kasapcopur O, et al.
Published: (2011)

Final validation of a new composite disease activity score for juvenile idiopathic arthritis: the Juvenile Arthritis Disease Activity Score (JADAS)
by: Consolaro A, et al.
Published: (2008)

Development and initial validation of the parent acceptable symptom state in juvenile idiopathic arthritis (JIA)
by: Filocamo G, et al.
Published: (2008)

Analysis of ceiling effect and score distribution of outcome measures in juvenile idiopathic arthritis (JIA)
by: Lattanzi B, et al.
Published: (2008)

JUVENILE DERMATOMYOSITIS
by: Sigrid Covaci, et al.
Published: (2016)

Agreement between physicians and parents in rating functional ability of children with juvenile idiopathic arthritis
by: Buoncompagni Antonella, et al.
Published: (2007)

Juvenile dermatomyositis (JDM) sine myositis
by: Schulz A, et al.
Published: (2011)

A meta-analysis to estimate the "real" placebo effect in juvenile idiopathic arthritis (JIA) trials
by: Martini A, et al.
Published: (2011)

Differences in therapeutic approach to juvenile dermatomyositis between Europe and Latin America
by: Trail L, et al.
Published: (2008)

MRI and ultrasound versus conventional measures of disease activity and structural damage in evaluating treatment efficacy in JIA. Do these imaging techniques have an additional value?
by: Viola S, et al.
Published: (2011)

MRI and ultrasound versus conventional measures of disease activity and structural damage in evaluating treatment efficacy in JIA. Do these imaging techniques have an additional value?
by: Viola S, et al.
Published: (2011)

Preliminary validation of the Juvenile Arthritis Multidimensional Assessment Report (JAMAR) in 403 clinic patients
by: Solari N, et al.
Published: (2008)

Juvenile Dermatomyositis in Pregnancy
by: Anthony Emeka Madu, et al.
Published: (2013)

The Vasculopathy of Juvenile Dermatomyositis
by: Charalampia Papadopoulou, et al.
Published: (2018)

Quantitative assessment of synovitis in juvenile idiopathic arthritis using Dynamic Contrast-Enhanced Magnetic Resonance Imaging
by: Malattia C, et al.
Published: (2008)

Juvenile Dermatomyositis with Generalized Edema
by: J Gordon Millichap
Published: (2001)

Gastroparesis associated with Juvenile Dermatomyositis
by: Martin N, et al.
Published: (2008)

Juvenile dermatomyositis in Western Switzerland
by: Hofer M, et al.
Published: (2011)

Respiratory involvement in juvenile dermatomyositis
by: Fabi M, et al.
Published: (2008)

What is the mortality of Juvenile Dermatomyositis (JDM) in the modern treatment era
by: Smith S, et al.
Published: (2008)

Juvenile dermatomyositis: clinical and laboratory charateristics of 18 patients
by: González MA, et al.
Published: (2011)

Impact of involvement of individual joint groups on subdimensions of functional ability scales in juvenile idiopathic arthritis
by: Meiorin S, et al.
Published: (2008)

Treatment of calcinosis with biphosphonates in juvenile dermatomyositis
by: Bilginer Y, et al.
Published: (2008)

Dyslipidemia in active juvenile dermatomyositis patients
by: Viana VST, et al.
Published: (2011)

Treatment and Clinical Outcome of Juvenile Dermatomyositis
by: Chih-Hsing Hung
Published: (2015)

Organ-specific autoantibodies and autoimmune diseases in juvenile systemic lupus erythematosus and juvenile dermatomyositis patients
by: Aikawa Nadia E, et al.
Published: (2012)

Development and initial validation of a new short and simple Health-Related Quality Of Life (HRQL) Questionnaire for Pediatric Rheumatic Diseases (PRD)
by: Palmisani E, et al.
Published: (2008)

2.4 Magnetic resonance imaging, ultrasonography and conventional radiography in the assessment of bone erosions in juvenile idiopathic arthritis
by: Malattia C, et al.
Published: (2008)

Increased vascular deposition of oxidized LDL in untreated juvenile dermatomyositis
by: Jacob C. Spitznagle, et al.
Published: (2024)

Agreement between objective and subjective definitions of inactive disease, remission and minimal disease activity in juvenile idiopathic arthritis
by: Davì S, et al.
Published: (2011)

Comparison of the accuracy of different definitions of clinical remission (CR) and minimal disease activity (MDA) in juvenile idiopathic arthritis (JIA)
by: Davì S, et al.
Published: (2008)

Is Anti-NXP2 Autoantibody a Risk Factor for Calcinosis and Poor Outcome in Juvenile Dermatomyositis Patients? Case Series
by: Natasa Toplak, et al.
Published: (2022)

Juvenile Dermatomyositis Early Onset, Case Report
by: Cagdas Boyvadoglu, et al.
Published: (2024)

Axillary Skin Ulcers in Infants with Juvenile Dermatomyositis
by: Hiroyuki Wakiguchi, et al.
Published: (2017)

Nodular Regenerative Hyperplasia of the liver in Juvenile Dermatomyositis
by: Aviya Lanis, et al.
Published: (2022)

Calcinosis as a complication of juvenile dermatomyositis (JDM)
by: Luz Contreras, et al.
Published: (2011)

Evaluation of the cardiovascular system in patients with juvenile dermatomyositis
by: Emeryk Andrzej, et al.
Published: (2011)

Comparison of physician's, parent's and patient's global ratings made on linear or 21-circle visual analogue scales (VAS) in juvenile idiopathic arthritis (JIA)
by: Dalprà S, et al.
Published: (2008)

Case of a fatal lung disease in a child with juvenile dermatomyositis
by: O.A. Oshlianska, et al.
Published: (2017)

Children with juvenile idiopathic arthritis currently followed in a tertiary care setting have a better psychosocial well-being than healthy peers
by: Suffia C, et al.
Published: (2011)